Privium Fund Management B.V. Roivant Sciences Ltd. Transaction History
Privium Fund Management B.V.
- $436 Million
- Q4 2024
A detailed history of Privium Fund Management B.V. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Privium Fund Management B.V. holds 215,506 shares of ROIV stock, worth $2.31 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
215,506
Previous 484,500
55.52%
Holding current value
$2.31 Million
Previous $5.59 Million
54.41%
% of portfolio
0.58%
Previous 1.39%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
505MCall Options Held
573KPut Options Held
739K-
Qvt Financial LP New York, NY65.8MShares$705 Million76.3% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X062.1MShares$665 Million6.45% of portfolio
-
Viking Global Investors LP47.8MShares$512 Million1.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA44.1MShares$472 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$379 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.54B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...